Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70

Journal of Bone and Mineral Research

Volumn 27, Issue 10, 2012, Pages 2085-2096

  Garbe, Annette I ^a   Roscher, Anne ^a   Schüler, Christiane ^b   Lutter, Anne Helen ^a   Glösmann, Martin ^b   Bernhardt, Ricardo ^c   Chopin, Michael ^a   Hempel, Ute ^a   Hofbauer, Lorenz C ^c   Rammelt, Stefan ^c   Egerbacher, Monika ^b   Erben, Reinhold G ^b   Jessberger, Rolf ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

BONE; F ACTIN; OSTEOCLASTS; RESORPTION; SWAP 70

Indexed keywords

CELL MARKER; COLONY STIMULATING FACTOR 1; F ACTIN; OSTEOCLAST DIFFERENTIATION FACTOR; PLECKSTRIN; REGULATOR PROTEIN; SWAP 70 PROTEIN; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW; BONE MASS; BONE REMODELING; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENE REARRANGEMENT; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION;

ACTINS; ANIMALS; BONE AND BONES; BONE RESORPTION; CELL LINE; CELL MOVEMENT; DNA-BINDING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MICE; NUCLEAR PROTEINS; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPETROSIS;

EID: 84866722090     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1670     Document Type: Article

References (52)

1. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423 (6937): 337-42. (Pubitemid 40852708)
2. Teitelbaum SL, Ross FP,. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003; 4 (8): 638-49. (Pubitemid 36917505)
3. Zaidi M,. Skeletal remodeling in health and disease. Nat Med. 2007; 13 (7): 791-801. (Pubitemid 47038187)
4. Vaananen HK, Zhao H, Mulari M, Halleen JM,. The cell biology of osteoclast function. J Cell Sci. 2000; 113 (Pt 3): 377-81. (Pubitemid 30116644)
5. Teitelbaum SL,. Bone resorption by osteoclasts. Science. 2000; 289 (5484): 1504-8.
6. Tolar J, Teitelbaum SL, Orchard PJ,. Osteopetrosis. N Engl J Med. 2004; 351 (27): 2839-49.
7. Askmyr MK, Fasth A, Richter J,. Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol. 2008; 140 (6): 597-609. (Pubitemid 351300923)
8. Faccio R, Novack DV, Zallone A, Ross FP, Teitelbaum SL,. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J Cell Biol. 2003; 162 (3): 499-509. (Pubitemid 36988558)
9. Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, Ginsberg MH, Ross FP, Teitelbaum SL,. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol. 2007; 176 (6): 877-88. (Pubitemid 46425547)
10. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W,. Vav3 regulates osteoclast function and bone mass. Nat Med. 2005; 11 (3): 284-90. (Pubitemid 40460556)
11. Ito Y, Teitelbaum SL, Zou W, Zheng Y, Johnson JF, Chappel J, Ross FP, Zhao H,. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J Clin Invest. 2010; 120 (6): 1981-93.
12. Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M,. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J Bone Miner Res. 2008; 23 (2): 260-70. (Pubitemid 351160040)
13. Shinohara M, Terada Y, Iwamatsu A, Shinohara A, Mochizuki N, Higuchi M, Gotoh Y, Ihara S, Nagata S, Itoh H, Fukui Y, Jessberger R,. SWAP-70 is a guanine-nucleotide-exchange factor that mediates signalling of membrane ruffling. Nature. 2002; 416 (6882): 759-63. (Pubitemid 34429154)
14. Ocana-Morgner C, Wahren C, Jessberger R,. SWAP-70 regulates RhoA/RhoB-dependent MHCII surface localization in dendritic cells. Blood. 2009; 113 (7): 1474-82.
15. Ihara S, Oka T, Fukui Y,. Direct binding of SWAP-70 to non-muscle actin is required for membrane ruffling. J Cell Sci. 2006; 119 (Pt 3): 500-7.
16. Pearce G, Audzevich T, Jessberger R,. SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70. Blood. 2011; 117 (5): 1574-84.
17. Borggrefe T, Keshavarzi S, Gross B, Wabl M, Jessberger R,. Impaired IgE response in SWAP-70-deficient mice. Eur J Immunol. 2001; 31 (8): 2467-75. (Pubitemid 32785366)
18. Borggrefe T, Masat L, Wabl M, Riwar B, Cattoretti G, Jessberger R,. Cellular, intracellular, and developmental expression patterns of murine SWAP-70. Eur J Immunol. 1999; 29 (6): 1812-22. (Pubitemid 29265536)
19. Gross B, Borggrefe T, Wabl M, Sivalenka RR, Bennett M, Rossi AB, Jessberger R,. SWAP-70-deficient mast cells are impaired in development and IgE-mediated degranulation. Eur J Immunol. 2002; 32 (4): 1121-8. (Pubitemid 34428829)
20. Sivalenka RR, Jessberger R,. SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration. Mol Cell Biol. 2004; 24 (23): 10277-88. (Pubitemid 39507866)
21. Sivalenka RR, Sinha M, Jessberger R,. SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis. Eur J Immunol. 2008; 38 (3): 841-54.
22. Quemeneur L, Angeli V, Chopin M, Jessberger R,. SWAP-70 deficiency causes high-affinity plasma cell generation despite impaired germinal center formation. Blood. 2008; 111 (5): 2714-24.
23. Pearce G, Angeli V, Randolph GJ, Junt T, von Andrian U, Schnittler HJ, Jessberger R,. Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nat Immunol. 2006; 7 (8): 827-34. (Pubitemid 44084089)
24. Lutter AH, Hempel U, Wolf-Brandstetter C, Garbe AI, Goettsch C, Hofbauer LC, Jessberger R, Dieter P,. A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix. J Cell Biochem. 2010; 109 (5): 1025-32.
25. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25 (7): 1468-86.
26. Erben RG,. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem. 1997; 45 (2): 307-13. (Pubitemid 27114500)
27. Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schuler C, Stolina M, Kostenuik PJ, Erben RG,. Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum. 2009; 60 (5): 1427-37.
28. Proell V, Xu H, Schuler C, Weber K, Hofbauer LC, Erben RG,. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats. Bone. 2009; 45 (4): 677-81.
29. Masat L, Caldwell J, Armstrong R, Khoshnevisan H, Jessberger R, Herndier B, Wabl M, Ferrick D,. Association of SWAP-70 with the B cell antigen receptor complex. Proc Natl Acad Sci USA. 2000; 97 (5): 2180-4. (Pubitemid 30134042)
30. Ross FP, Teitelbaum SL,. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev. 2005; 208: 88-105. (Pubitemid 41746387)
31. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T,. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 1999; 190 (12): 1741-54. (Pubitemid 30013841)
32. Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL,. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest. 2003; 111 (5): 749-58. (Pubitemid 36278593)
33. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y,. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol. 2006; 24: 33-63.
34. Takayanagi H,. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5 (12): 667-76.
35. Lorenzo J, Horowitz M, Choi Y,. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008; 29 (4): 403-40. (Pubitemid 351831507)
36. Nakamura I, Takahashi N, Jimi E, Udagawa N, Suda T,. Regulation of osteoclast function. Mod Rheumatol. 2012; 22 (2): 167-77.
37. Palokangas H, Mulari M, Vaananen HK,. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J Cell Sci. 1997; 110 (Pt 15): 1767-80. (Pubitemid 27352856)
38. Maeda H, Akasaki K, Yoshimine Y, Akamine A, Yamamoto K,. Limited and selective localization of the lysosomal membrane glycoproteins LGP85 and LGP96 in rat osteoclasts. Histochem Cell Biol. 1999; 111 (4): 245-51. (Pubitemid 29155514)
39. Teitelbaum SL,. Osteoclasts: what do they do and how do they do it?. Am J Pathol. 2007; 170 (2): 427-35. (Pubitemid 47339379)
40. Babb SG, Matsudaira P, Sato M, Correia I, Lim SS,. Fimbrin in podosomes of monocyte-derived osteoclasts. Cell Motil Cytoskeleton. 1997; 37 (4): 308-25. (Pubitemid 27327563)
41. Hurst IR, Zuo J, Jiang J, Holliday LS,. Actin-related protein 2/3 complex is required for actin ring formation. J Bone Miner Res. 2004; 19 (3): 499-506. (Pubitemid 38787406)
42. McMichael BK, Kotadiya P, Singh T, Holliday LS, Lee BS,. Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. Bone. 2006; 39 (4): 694-705. (Pubitemid 44311723)
43. Tehrani S, Faccio R, Chandrasekar I, Ross FP, Cooper JA,. Cortactin has an essential and specific role in osteoclast actin assembly. Mol Biol Cell. 2006; 17 (7): 2882-95. (Pubitemid 43993494)
44. Ma T, Sadashivaiah K, Madayiputhiya N, Chellaiah MA,. Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. J Biol Chem. 2010; 285 (39): 29911-24.
45. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF, Hruska KA,. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem. 2000; 275 (16): 11993-2002. (Pubitemid 30237772)
46. Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow J, Chambers T, Thrasher AJ,. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood. 2004; 103 (9): 3552-61. (Pubitemid 38525693)
47. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR,. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest. 1992; 90 (4): 1622-7.
48. Lakkakorpi PT, Nakamura I, Young M, Lipfert L, Rodan GA, Duong LT,. Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts. J Cell Sci. 2001; 114 (Pt 1): 149-60. (Pubitemid 32118065)
49. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL,. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest. 2000; 105 (4): 433-40. (Pubitemid 30127243)
50. Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE,. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science. 1972; 177 (4051): 793-5.
51. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T,. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J Immunol. 1985; 135 (4): 2562-8. (Pubitemid 16215850)
52. Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T,. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res. 1999; 78 (10): 1617-23. (Pubitemid 32501249)